Login / Signup
Tae Ho Kim
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 3
Top Topics
Subarachnoid Hemorrhage
Advanced Non Small Cell Lung Cancer
Anti Inflammatory
Epidermal Growth Factor Receptor
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Eun Ji Lee
,
Seung Yeon Oh
,
You Won Lee
,
Ju Young Kim
,
Min-Je Kim
,
Tae Ho Kim
,
Jii Bum Lee
,
Min Hee Hong
,
Sun Min Lim
,
Anke Baum
,
Lydia Woelflingseder
,
Harald Engelhardt
,
Mark Petronczki
,
Flavio Solca
,
Mi Ran Yun
,
Byoung Chul Cho
Discovery of a novel potent EGFR inhibitor against EGFR activating mutations and on-target resistance in NSCLC.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2024)
Eun Ji Lee
,
Seung Yeon Oh
,
You Won Lee
,
Ju Young Kim
,
Min-Je Kim
,
Tae Ho Kim
,
Jii Bum Lee
,
Min Hee Hong
,
Sun Min Lim
,
Anke Baum
,
Lydia Woelflingseder
,
Harald Engelhardt
,
Mark Petronczki
,
Flavio Solca
,
Mi Ran Yun
,
Byoung Chul Cho
Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (8) (2024)
Eun Ji Lee
,
Seung Yeon Oh
,
You Won Lee
,
Ju Young Kim
,
Min-Je Kim
,
Tae Ho Kim
,
Jii Bum Lee
,
Min Hee Hong
,
Sun Min Lim
,
Anke Baum
,
Lydia Woelflingseder
,
Harald Engelhardt
,
Mark Petronczki
,
Flavio Solca
,
Mi Ran Yun
,
Byoung Chul Cho
Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (8) (2024)